Four People Given the New COVID Vaccine in Clinical Trials Developed Bell’s Palsy Should You Be Worried? Health.com 12/10/2020 Claire Gillespie
A document released on December 8, ahead of the Vaccines and Related Biological Products Advisory Committee (VRBPAC) meeting on December 10, reveals more details about the Pfizer COVID-19 vaccine which is expected to be the first to be authorized for emergency use in the US.
The document reveals that four cases of Bell s palsy, a condition that causes temporary facial paralysis, were identified in study participants who received the vaccine but in none of the participants who received a placebo. At least one of the patients has recovered, and there s no evidence that the vaccine caused the problem. Here s what to know about this condition.
A document released on December 8, ahead of the Vaccines and Related Biological Products Advisory Committee (VRBPAC) meeting on December 10, reveals more details about the Pfizer COVID-19 vaccine which is expected to be the first to be authorized for emergency use in the US.
The document reveals that four cases of Bell s palsy, a condition that causes temporary facial paralysis, were identified in study participants who received the vaccine but in none of the participants who received a placebo. At least one of the patients has recovered, and there s no evidence that the vaccine caused the problem. Here s what to know about this condition.